Restoration of renal function does not correct impairment of uremic HDL properties

Area of Science:

• Nephrology
• Cardiology
• Biochemistry

Background:

• Cardiovascular disease is the primary cause of mortality in renal transplant recipients.
• The specific mechanisms driving this cardiovascular risk remain unclear.
• Dysfunctional high-density lipoprotein (HDL) has been implicated in end-stage renal disease (ESRD).

Purpose of the Study:

• To investigate whether HDL retains structural and functional abnormalities post-renal transplantation.
• To compare HDL properties in stable renal transplant recipients with varying graft function and ESRD patients.

Main Methods:

• Systematic analysis of HDL from renal transplant recipients and ESRD patients.
• Assessment of cholesterol acceptor capacity and antioxidative activity of HDL.
• Mass spectrometry to identify protein composition of HDL.

Main Results:

• HDL function, including cholesterol acceptor capacity and antioxidative activity, was significantly impaired in kidney transplant recipients, irrespective of graft function.
• These functional deficits in HDL were comparable to those observed in ESRD patients.
• Mass spectrometry revealed unique protein remodeling in transplant HDL, with enrichment of specific proteins like α-1 microglobulin/bikunin precursor and serum amyloid A.

Conclusions:

• HDL in kidney transplant recipients exhibits profound molecular and functional alterations.
• These dysfunctional HDL characteristics may play a direct pathological role in the elevated cardiovascular risk within this population.
• Further research into HDL modification could inform strategies to mitigate cardiovascular complications after transplantation.